Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience

por Srinivasa, BJ, Lalkota, Bhanu Prakash, Badarke, Girish, Hazarika, Diganta, Mohammad, Nasiruddin, Sapkota, Sulav, Khanderia, Mansi, Tousif, D, Rao, Raghavendra, Ram, Amritanshu, Patil, Shekar, Naik, Radheshyam
Publicado 2018